España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Bristol-Myers Squibb
BMY
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$55.83
0.04
0.07%
At close: -
$56.00
0.17
0.30%
After Hours: 7:53 PM EDT
Get Report
Comment
Bristol-Myers Squibb (BMY) Forecast
News
Earnings
Bristol-Myers Squibb (BMY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Bristol-Myers Squibb (NYSE:BMY) Stock
Bristol-Myers Squibb Stock (NYSE: BMY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, February 21, 2025
Why Is Cancer-Focused Exelixis Stock Trading Higher On Friday?
Vandana Singh
Thursday, February 20, 2025
BioArctic And Bristol Myers Squibb Finalize $...
Benzinga Newsdesk
Wednesday, February 19, 2025
Bristol Myers Cancer Drug Opdivo In Combination With Chemo Shows Improved Overall Survival In Certain Patients With Lung Cancer
Vandana Singh
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields
Avi Kapoor
Bristol Myers Squibb Announced The Final Anal...
Benzinga Newsdesk
Tuesday, February 18, 2025
Trump's Tax Cut Could Add $4.6 Trillion To Deficit, With $48 Billion Tax Relief For Top 100 Firms: Robert Reich
Rishabh Mishra
Monday, February 17, 2025
Bristol Myers Squibb Says New 5-Year Sotyktu ...
Benzinga Newsdesk
Thursday, February 13, 2025
Bristol Myers Squibb Phase 3 RELATIVITY-098 T...
Benzinga Newsdesk
Wednesday, February 12, 2025
Bristol-Myers Squibb Unusual Options Activity
Benzinga Insights
Monday, February 10, 2025
What's Going On With Bristol Myers Squibb Stock On Monday?
Vandana Singh
Bristol-Myers Squibb shares are trading lower...
Benzinga Newsdesk
Bristol Myers Reports Topline Results for Bre...
Benzinga Newsdesk
Friday, February 07, 2025
Wells Fargo Maintains Equal-Weight on Bristol...
Benzinga Newsdesk
US Stocks Likely To Open On A Mixed Note: Amazon, Pinterest, Take-Two Among Stocks To Watch
Rounak Jain
S&P 500 Gains For 3rd Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
Avi Kapoor
Thursday, February 06, 2025
Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday?
Piero Cingari
Live On CNBC, Josh Brown Announces Sold Brist...
Benzinga Newsdesk
Dow Dips 150 Points; Bristol Myers Squibb Issues Weak Outlook
Avi Kapoor
Bristol Myers Squibb Warns Near-Term Impact Due To Generics On 2025 Sales Forecast, Outlines $2 Billion In Additional Cost Cuts
Vandana Singh
Bristol-Myers Squibb FY25 Outlook: Adj EPS $6...
Benzinga Newsdesk
Bristol-Myers Squibb shares are trading lower...
Benzinga Newsdesk
Bristol Myers Squibb Expects 2025 Sales Of Ar...
Benzinga Newsdesk
Bristol-Myers Squibb Q4 2024 Adj EPS $1.67 Be...
Benzinga Newsdesk
US Stocks Likely To Open Higher Ahead Of Amazon's Earnings: 'Buy The Dip' Mentality Remains Prevalent, Says Analyst
Rishabh Mishra
Earnings Scheduled For February 6, 2025
Benzinga Insights
Dow Rises Over 300 Points As Nvidia Surges: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
Avi Kapoor
Bristol-Myers Squibb, Amazon And 3 Stocks To Watch Heading Into Thursday
Avi Kapoor
Tuesday, February 04, 2025
Live On CNBC, Josh Brown Announces Bought Bri...
Benzinga Newsdesk
McDonald's To $290? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
Cantor Fitzgerald Maintains Neutral on Bristo...
Benzinga Newsdesk
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Avi Kapoor
Friday, January 31, 2025
Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts
Nabaparna Bhattacharya
Bristol Myers Squibb Says Committee For Medic...
Benzinga Newsdesk
Bristol Myers Squibb Gets Positive CHMP Opini...
Benzinga Newsdesk
Tuesday, January 28, 2025
Deep Dive Into Bristol-Myers Squibb Stock: Analyst Perspectives (9 Ratings)
Benzinga Insights
Citigroup Maintains Neutral on Bristol-Myers ...
Benzinga Newsdesk
Monday, January 27, 2025
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Reported Saturday, Bristol Myers Squibb Share...
Benzinga Newsdesk
Wednesday, January 22, 2025
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
Vandana Singh
Tuesday, January 21, 2025
Bristol-Myers Squibb Options Trading: A Deep Dive into Market Sentiment
Benzinga Insights
Friday, January 17, 2025
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
Anthony Noto
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
Vandana Singh
'Ozempic Is In The Next Round Of Medicare Dru...
Benzinga Newsdesk
Monday, January 13, 2025
Like Bristol-Myers Squibb And AbbVie, Johnson & Johnson Seeks To Bolster Neuropsychiatric Portfolio With $15 Billion Deal
Vandana Singh
ArsenalBio Says Bristol Myers Squibb Exercise...
Benzinga Newsdesk
Friday, January 10, 2025
Decoding Bristol-Myers Squibb's Options Activity: What's the Big Picture?
Benzinga Insights
Thursday, January 09, 2025
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
Vandana Singh
Wednesday, January 08, 2025
Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators
Chandrima Sanyal
Salesforce To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
Truist Securities Maintains Buy on Bristol-My...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch